During the process of lymphopoiesis, hematopoietic stem cells (HSC) become restricted to lymphoid development and then committed to B-or T-cell lineages. This process results in the production of intermediate multipotent cell populations that have the capacity to dierentiate into distinct cell types. For example, a bipotent progenitor is capable of producing unipotent progenitor cells that become committed to either the T or natural killer (NK) cell lineages (Carlyle et al., 1997; Leclercq et al., 1996; Matsuzaki et al., 1993; Rodewald et al., 1992; Sanchez et al., 1994) . Committed T-cell progenitors can then further give rise to T cells expressing either ab or gd T-cell receptor (TCR) genes. Similarly, B lymphocytes develop from a common lymphocyte precursor cell (Kondo et al., 1997) .
Multipotent progenitor cells migrate to the thymus from the embryonic fetal liver or adult bone marrow. Cells that commit to the T-cell lineage begin an ordered pattern of dierentiation characterized by the acquisition and loss of de®ned cell surface molecules as well as TCR gene rearrangements (Zuniga-P¯ucker and Lenardo, 1996) . Double-negative (DN) T cells lack cell surface expression of CD4, CD8 and TCR. This double-negative population can be further divided into four distinct populations, DNI ± DNIV, based on the surface expression pro®le of CD44 and CD25 and TCR gene rearrangement status (Godfrey and Zlotnik, 1993) . CD44 + CD25
7 DNI cells have unrearranged TCR genes and represent the most immature stage of thymocyte development. Progenitor cells within the DNI population are capable of giving rise to NK-and T-cell lineages. DNI cells can further be divided into two fractions based on CD122 expression. CD44 + CD25 7 CD122 + cells exclusively contain NKcell progenitors (Ikawa et al., 1999) . DNI cells subsequently dierentiate into CD44 + CD25 + DNII cells that express the recombination activating gene (RAG) proteins and begin to rearrange their TCRb chain genes (Shortman and Wu, 1996) . At the DNIII stage, signals generated through a rearranged TCRb chain gene and preTa lead to a cessation of RAG gene expression and further TCRb chain gene rearrangements. CD44 and CD25 are subsequently downregulated at the DNIV stage followed by an upregulation of CD8. If the TCRb chain gene rearrangement encodes a functional gene product, CD4 is then upregulated and the resulting CD4CD8 DP thymocytes re-express the RAG genes and commence TCRa chain gene rearrangements. Following successful TCRa chain gene rearrangements, DP thymocytes undergo a TCR-mediated selection process. DP thymocytes reacting with low anity to selfpeptide MHC complexes are positively selected and survive (von Boehmer, 1994) . DP cells expressing receptors that interact with high anity to self peptide-MHC complexes are negatively selected and undergo apoptosis (Nossal, 1994) . DP thymocytes that do not react with self peptide-MHC complexes die by default. Surviving DP thymocytes then down regulate either CD4 or CD8 to become mature single positive (SP) thymocytes.
B-cell development in the bone marrow is also driven by antigen receptor gene rearrangements and characterized by the expression of cell surface markers (Hardy et al., 1991; Kee and Paige, 1995) . Similar to Tcell development, progenitors destined for commitment to the B-cell lineage arise from multipotent precursor cells. Once a B-cell becomes committed to the Blymphocyte developmental pathway, rearrangement of the m immunoglobulin heavy (IgH) chain gene begins while the Ig k and l light-chain genes remain in the germline con®guration. If successful IgH chain gene rearrangement occurs, these B220 + CD43 + pro-B cells express the rearranged heavy-chain on the cell surface in association with the surrogate light-chain genes Vpre-B and l5.
Signals generated through this pre-B-cell receptor induce Ig light-chain gene rearrangements and the resulting pre-B cells downregulate cell surface expres-sion of CD43. At the immature B-cell stage, successfully rearranged heavy and light chain genes are expressed in association on the cell surface and the B cells can exit the bone marrow. In the spleen, B cells mature to IgM + IgD + lymphocytes. Upon encounter with antigen, mature B cells are activated and become either low anity plasmacytes or enter germinal centers. In the germinal centers, antigen-primed T cells and antigen presenting cells induce B-cell expansion, isotype switching and somatic hypermutation (MacLennan, 1994) . B cells can then terminally dierentiate into high anity antibody secreting cells or memory B cells.
E-proteins and lymphocyte development
Several transcription factor families have been shown to be crucial for lineage commitment as well as lymphocyte function. Basic helix ± loop ± helix (bHLH) proteins represent one such class of transcription factors required for these processes. Members of this class of proteins include the E proteins E12 and E47, which are dierentially spliced products of the E2A gene, and HEB and E2-2 which are encoded by separate genes (Henthorn et al., 1990; Hu et al., 1992; Murre et al., 1989) . High anity binding to Ebox DNA consensus motifs requires the presence of a highly conserved helix ± loop ± helix dimerization domain and adjacent basic region. Two additional highly conserved N-terminal domains, AD1 and AD2, mediate bHLH protein transcriptional activity (Massari et al., 1996; Quong et al., 1993) . By acting as dimerization partners for tissue restricted bHLH proteins, E proteins regulate the speci®cation of many tissue fates.
The high level of E-protein transcripts in the bone marrow, spleen, and thymus suggested that these proteins function in lymphocyte development. In Blineage cells, E-box DNA binding complexes are composed of E12 and E47 homodimers (Bain et al., 1993; Jacobs et al., 1993; Shen and Kadesch, 1995) . HEB and E2A are highly expressed in the thymus and form heterodimeric DNA binding complexes (Bain et al., 1997a; Sawada and Littman, 1993) . In the spleen, E2A-proteins are expressed at high levels in the dark zone of germinal centers (Goldfarb et al., 1996; Roberts et al., 1993) . In vivo, treatment of puri®ed splenic B cells with LPS or IL-4 in combination with anti-IgM, anti-CD40 or anti-CD38, induces E2A protein levels and DNA binding activity (Quong et al., 1999) .
Recent data have identi®ed B-lineage speci®c target genes for the E-proteins. Ectopic expression of E2A-proteins in lymphoid cell lines leads to upregulation of the B-cell-speci®c genes early B-cell factor (EBF), Pax-5, l5 and Vpre-B as well as RAG-1 (Kee and Murre, 1998) . E2A proteins also have the ability to induce rearrangement of IgH or k light chain receptor gene loci when overexpressed in pre-T or non-lymphoid cells lines (Romanow et al., 2000; Schlissel et al., 1991) .
The generation of E-protein de®cient mice provided an invaluable tool for studying E-protein function in vivo. In E2A de®cient mice, the complete absence of B lymphocytes was the most striking defect observed (Bain et al., 1994; Zhuang et al., 1994) . Even the earliest immunoglobulin rearrangements were lacking in E2A de®cient mice, demonstrating the requirement for E2A proteins in commitment to the B-cell lineage (Bain et al., 1994) . Furthermore, the expression of RAG1 and 2 as well as transcripts for the B-cell speci®c genes Pax-5, CD19, mb-1 and l5 were absent from the fetal liver and adult bone marrow of these mice (Bain et al., 1994 (Bain et al., , 1997b . HEB and E2-2 are not required for B-cell lineage commitment. However, HEB and E2-2 null mutant mice showed half the number of pro-B cells in the fetal liver indicating a role for HEB and E2-2 at early stages of Blymphocyte development (Zhuang et al., 1996) . Additionally, mice heterozygous for any two Eproteins showed a B-cell phenotype similar to that observed in E2-2 or HEB de®cient mice suggesting a partial overlap in E-protein function at early stages of B-lymphocyte development (Zhuang et al., 1996) . At later stages E-proteins are required to promote isotype switching (Goldfarb et al., 1996; Quong et al., 1999) . Thus, E-proteins play distinct roles at multiple stages of B-cell maturation.
E-protein de®cient mice also showed dramatic defects in T-cell development. E2A mutant mice are blocked at the CD44 + CD25 7 DNI stage, prior to Tlineage commitment (Bain et al., 1997a) (Figure 1 ). These mice also show enhanced maturation of DP thymocytes, resulting in an increased percentage of mature SP thymocytes and a concomitant decrease in the percentage of DP thymocytes (Bain et al., 1997a) . In addition to defective ab T-cell development, E2A null mutant mice show perturbations in the development of gd T cells (Bain et al., 1999b) . Along with a reduction in the absolute number of gd T cells, the gd T cells that are present in adult E2A de®cient mice express Vg3 and Vd1, TCRs that are almost exclusively expressed during normal murine fetal development (Bain et al., 1999b) . Although the mechanism has yet to be determined, this result shows the importance of E2A proteins in regulating gene rearrangement. Thymocyte development in HEB de®cient mice is partially blocked at the DNIII stage and at the transition of thymocytes from the immature single positive stage (ISP) to the DP stage (Zhuang et al., 1996) . In contrast to E2A null mutant mice, HEB mutant mice do not show altered gd T-cell development and show normal thymocyte maturation during the transition of the DP to the SP cell stage (Barndt et al., 1999) .
Id proteins
While E proteins function as transcriptional activators, other classes of HLH proteins function as inhibitory molecules. Inhibitory HLH proteins which lack a basic region include Id1, Id2, Id3, Id4 and the drosophila protein extramacrochaetae (emc) (Benezra et al., 1990; Christy et al., 1991; Deed et al., 1992; Ellis et al., 1990; Garrell and Modolel, 1990; Riechmann et al., 1994; Sun et al., 1991) . All Id proteins have the ability to heterodimerize with E-proteins in vitro. However, because Id molecules lack a basic region these heterodimeric complexes cannot bind DNA (Benezra et al., 1990) . As a result of inhibiting E-protein DNA binding, Id proteins also inhibit E-box dependent activation of E-protein target genes. This loss of E protein activity can result in the loss of tissue speci®c gene expression and a disruption of the dierentiation program in dierent cell types (Chen et al., 1997; Desprez et al., 1995; Jen et al., 1992; Kreider et al., 1992; Moldes et al., 1997; Shoji et al., 1994) .
Id proteins are expressed in lymphoid tissues including the fetal liver, bone marrow, spleen and thymus (Christy et al., 1991; Ikawa et al., 2001; Riechmann et al., 1994; Rivera et al., 2000) . Early studies in B-cell lines showed that Id proteins are highly expressed in pro-B cells and that their levels of expression decreased upon maturation (Sun et al., 1991; Wilson et al., 1991) . In B cells, expression of these proteins was shown to repress transcriptional activity of the IgH and k intronic as well as the k3' enhancer (Pongubala and Atchison, 1991; Sun et al., 1991; Wilson et al., 1991) . Similarly, Id proteins repress CD4 enhancer activity in T cells (Sawada and Littman, 1993) . These data strongly suggested that Id proteins function through their ability to block E-protein activity. However, de®nitive evidence for a direct interaction in vivo between Id and E-proteins has come from genetic analysis of compound null mutant mice carrying the Id1 or Id3 and E2A null mutant alleles (Rivera et al., 2000; Yan et al., 1997).
HLH proteins and maturation to the NK and dendritic cell lineage
T-lymphocytes and NK cells develop from multipotent lymphoid progenitor cells. Bipotent T/NK progenitors (p-T/NK) then become further restricted to become unipotent progenitors of the T (p-T) or NK (p-NK) cell lineages. Transgenic mice expressing Id1 or Id2 under control of the lck proximal promoter show developmental defects similar to those described for E2A and HEB de®cient mice (Kim et al., 1999; Morrow et al., 1999) . Using a similar approach, human CD34 + CD1a 7 p-T/NK bipotent progenitors were transduced with retroviruses expressing the HLH inhibitor protein Id3. Interestingly, whereas T-lineage development was blocked, CD56 + NK cells developed normally (Heemskerk et al., 1997) . Similarly, NK cell development in mice de®cient for the Id2 gene is severely perturbed (R Rivera and C Murre, unpublished results; Yokota et al., 1999) .
In thymocytes from wild-type mice, Id2 is expressed at the DNI stage of DN development and downregulated at subsequent DN stages, while mRNA levels of the bHLH proteins E2A and HEB are constant at all DN stages (Ikawa et al., 2001 population (Ikawa et al., 2001) . These data suggest a model in which Id2 upregulation in p-T/NK bipotent precursors overcomes E2A protein activity leading to the maturation of NK cells (Figure 2) .
In humans, dendritic cells are derived from CD34 + progenitor cell populations present within the thymus and fetal liver. While DC1 dendritic cells appear to Regulation and function of Id proteins in lymphocyte development R Rivera and C Murre originate from myeloid cell precursors, DC2 dendritic cells appear to arise from lymphoid cell precursors (Ardavin et al., 1993; Matsuzaki et al., 1993; Res et al., 1999; Rissoan et al., 1999) . Interestingly, ectopic expression of Id2 or Id3 in CD34 + cells strongly inhibited the production of preDC2 cells, indicating that the inhibitory activity of the Id2 and Id3 proteins is through E-protein sequestration (Spits et al., 2000) . In summary, these data indicate that NK and preDC2 cell development is regulated at least in part by the activities of HLH proteins (Figure 3 ).
Id proteins and peripheral lymphoid organ development
In addition to the absence of NK cells, Id2 de®cient mice also exhibit a striking absence of Peyer's patches and peripheral lymph nodes (R Rivera and C Murre, unpublished results; Yokota et al., 1999) . Transfer of bone marrow from Id2 de®cient mice into lethally irradiated hosts demonstrated that lymphocytes from the Id2 null mutant mice are not defective in homing to peripheral lymphoid organs (R Rivera and C Murre, unpublished results; Yokota et al., 1999) . This was further con®rmed by the presence of adhesion molecules necessary for homing to peripheral lymphoid organs on Id2 de®cient lymphocytes (Yokota et al., 1999) . The transfer of wild-type bone marrow cells into lethally irradiated Id2 knockout mice did not result in the appearance of visible Peyer's patches or peripheral lymph nodes (Yokota et al., 1999) . These results indicate that the peripheral lymph node defect observed in Id2 null mutant mice is due to an intrinsic developmental defect in the generation of secondary lymphoid organs. We note that mice de®cient for lymphotoxin a or b show a similar phenotype to Id2 de®cient mice (Koni et al., 1997; Togni et al., 1994) . Lymphotoxin (LT) is generated by CD4 + CD3
7 IL-7Ra + cells in the embryonic gut and secondary lymphoid organs (Mebius et al., 1997) . In situ hybridization of embryonic intestines with LTa and b probes and¯ow cytometric analysis of cells isolated from the embryonic gut showed that this population of cells was essentially absent in Id2 de®cient mice (Yokota et al., 1999) . Thus, Id2 is required for growth and survival of LT producing cells. Alternatively, Id2 may repress a bHLH protein that negatively regulates LT producing cell production.
Id proteins and the regulation of thymocyte maturation
In addition to early thymocyte defects, E2A de®cient mice also exhibited abnormalities at later stages of Tlineage development. These mice showed a signi®cant decrease in the proportion of mature DP thymocytes and a corresponding increase in the percentage of both CD4 and CD8 thymocytes (Bain et al., 1997a) . Further analysis showed that the presence of E47 is required for lymphocyte survival at the DP cell stage and proper maturation into SP cells (Bain et al., 1999a) . Thus, E2A proteins play an important role during the transition of DP into mature SP cells.
In the thymus, Id2 and Id3 proteins are highly expressed. In addition, Id3 has been shown to interact with E-proteins in vivo (Rivera et al., 2000) . To test the hypothesis that a downregulation of E2A proteins allows DP thymocytes to mature to the SP stage, 16610D9, a murine DP cell line with characteristics of normal DP thymocytes, was transduced with Id3 expressing retrovirus (Bain et al., 1999a) . Expression of Id3 in these cells caused an upregulation of CD5, CD69, ab TCR, and CD44 and a downregulation of HSA. Additionally, CD4 and CD8 were downregulated (Bain et al., 1999a) . These events are signi®cant in that they re¯ect events that normally occur during thymocyte maturation. More importantly, these phenotypic changes coincide with a decrease in E2A binding activity.
Further evidence to support the theory that a downregulation of E2A is necessary for normal DP to SP transition came from studies in Id3 de®cient mice. These mice display a late thymic phenotype that is opposite to that seen in E2A de®cient mice. Brie¯y, thymocyte development in Id3 null mutant mice is severely blocked during the transition of DP to SP cells (Rivera et al., 2000) (Figure 1 ). In contrast, Id2 null mutant thymocytes do not display defects in positive selection (R Rivera and C Murre, unpublished results). It is conceivable that this is due to a functional compensation by Id3. Recent genetic data have suggested that Id3 and E2A interact to regulate the DP to SP transition, providing in vivo evidence for the presence E2A/Id3 heterodimers within developing thymocytes (Rivera et al., 2000) . These observations indicate that the balance of E-proteins and Id gene products, play essential roles during thymocyte maturation.
Id proteins are required for H-Y TCR transgene mediated thymocyte deletion
In male H-2b mice, expression of the H-Y TCR transgene results in thymocyte deletion characterized by decreased total thymocyte numbers and very few thymocytes that progress to the DP stage (Kisielow et al., 1988) . However, in male Id3 null mutant H-Y TCR transgenic mice, thymocyte deletion is severely inhibited. These mice show a large proportion of DP thymocytes and increased thymocyte cell numbers when compared to H-Y transgenic male littermates (Rivera et al., 2000) . In contrast, Id3 de®cient thymocytes undergo normal deletion in response to endogenous superantigens (Rivera et al., 2000) . Superantigen mediated deletion is MHC class II dependent. Preliminary data indicate that the inability of Id3 de®cient thymocytes to undergo H-Y mediated negative selection is not intrinsic to the Tcell lineage (R Rivera and C Murre, unpublished results). How Id3 contributes to H-Y mediated negative selection is an intriguing question and remains to be resolved.
HLH proteins and B-cell activation
In primary mature B-lymphocytes, E2A protein levels and DNA binding activity are low. However, when activated in vitro, E2A protein levels and DNA binding are strongly induced (Quong et al., 1999) . Interestingly, ectopic expression of Id proteins inhibited Ig isotype switching in both cell lines and primary B cells (Goldfarb et al., 1996; Quong et al., 1999) . Examination of genomic DNA from the Id3 transduced B cells revealed that class switch recombination was inhibited (Quong et al., 1999) . Interestingly, in both experiments, germline transcripts were not eected by Id3 expression. These results indicate that E2A proteins play a role in isotype switching downstream of germline transcription and may be required for proper regulation of genes required for the class switch recombination machinery.
Id3 de®cient mice also display defects in humoral immunity. These mice have unusually low serum levels of IgG1 and IgG2a antibody isotypes (Pan et al., 1999) . B cells from these mice display normal cell surface activation markers when stimulated with antiIgM or LPS in vitro. However, when these mice are challenged with T-dependent or T-independent antigen they exhibit a perturbed immune response characterized by a decreased production of speci®c Ig isotypes (Pan et al., 1999) . This result argues that Id3 is necessary for isotype switching. However, it is important to note that a de®ciency in Id3 could alter the activity of other cell types required for isotype switching or inhibit clonal expansion of activated B cells in vivo. How Id3 functions during the later stages of B cell development is an important question and will need to be addressed by further studies.
Id3 expression is regulated by the Ras ERK MAPK pathway
DP thymocyte maturation is dependent in part on the action of Src family protein tyrosine kinases which signal through the activation of the mitogen activated protein tyrosine kinase (MAPK) cascade. For example, DP thymocyte maturation requires the activation of p56 lck by the TCR complex. Activation of Lck leads to phosphorylation of CD3e and CD3x which activate the non-receptor tyrosine kinases, ZAP70 and Syk (Clements et al., 1999) . Subsequently, the activation of ZAP70 and Syk leads to intracellular calcium release and the activation of the Ras/Raf/MEK/ERK MAP kinase pathway. The non-receptor tyrosine and MAP kinase pathways are activated by various external signals in a wide variety of cell types. In particular, the ERK MAP kinase module has been well studied and implicated in various aspects of cellular dierentiation, cell survival, proliferation, as well as oncogenesis (Brunet and Pouyssegur, 1997; Marshall, 1995; Nishida and Gotoh, 1993; Seger and Krebs, 1995) .
The de®ciency in thymocyte maturation in Id3 de®cient mice is similar to defects observed in mice expressing dominant negative forms of the MAPKK, MEK-1, or mice lacking the MAPK, ERK-1 (AlberolaIla et al., 1995; Pages et al., 1999) . Recently, we have established a link between ERK MAP kinase signaling and the HLH transcriptional regulators E2A, HEB and Id3. Speci®cally, these data demonstrated that Id3 gene expression is regulated by the Ras ERK MAP kinase pathway, resulting in a signi®cant reduction in E2A/ HEB DNA binding activity (Bain et al., 2001) . Thus, signals emanating from the TCR activate Id3 gene expression and lower E2A and HEB DNA binding activity. Decreased levels of E2A/HEB heterodimers would then promote DP dierentiation. This hypothesis is consistent with the phenotypes described for E2A and Id3 de®cient mice.
EGR1 is a zinc ®nger containing protein that is activated by signals originating from the TCR during positive selection (Topiliko et al., 1997) . Mice overexpressing EGR1 in the thymus show enhanced positive selection even in a non-selecting background (Miyazaki and Lemonnier, 1998) . Previous data have implicated EGR1 as a key regulator of Id1 gene expression (Tournay and Benezra, 1996) . Recent experiments show that TCR ligation induces an increase in EGR1 mRNA levels in DP thymocytes (Bain et al., 2001) . This increase in EGR1 mRNA levels is sensitive to a pharmacological inhibitor of MAP kinase signaling (Bain et al., 2001) . When overexpressed in a DP cell line, EGR1 causes a rapid induction of Id3 mRNA levels and a subsequent decrease in E-protein DNA binding activity (Bain et al., 2001) . Thus an induction of EGR1 via the MAPK pathway leads to an upregulation of Id3 levels, a downregulation of E-protein DNA binding activity, and ultimately, promotion of thymocyte maturation ( Figure 4A ).
Linking the p56
lck , Ras, ERK MAP kinase pathway and Id with transformation The E2A proteins have been implicated in growth control, programmed cell death and hematopoeitic malignancies. Mice carrying targeted mutations in the E2A locus rapidly develop highly malignant T-cell lymphomas (Bain et al., 1997a; Yan et al., 1997) . Additionally, inappropriate expression of Id1 and Id2 in thymocytes promotes lymphomagenesis (Morrow et al., 1999) . Lymphomas lacking E2A undergo apoptosis when this gene is reintroduced, suggesting that the E2A proteins function as tumor suppressors (Engel and Murre, 2000) . Furthermore, ectopic expression of E2A in human T-ALL cell lines was shown to inhibit cell cycle progression and promote apoptosis, linking the inactivation of E2A with the progression of human Tcell acute lymphoblastic leukemia (T-ALL) (Park et al., 1999) .
Interestingly, both the p56 lck and ERK MAP kinase cascades have been implicated in the development of Tcell lymphomas. Ectopic expression of p56 lck in transgenic mice leads to rapid development of T-cell lymphomas, with similar kinetics and phenotype as described for E2A de®cient and Id1 and Id2 transgenic mice (Abraham et al., 1991; Bain et al., 1997a; Kim et al., 1999; Morrow et al., 1999; Yan et al., 1997) . Additionally, constitutive expression of MEK1 in transgenic mice has been reported to lead to thymocyte transformation (Gartner et al., 1999) . These data bring together the Ras MAP kinase pathway, Id proteins and the tumor suppressor E2A in a common pathway. Another oncoprotein, TpL2 or Cot has also been linked with the ERK MAP kinase module. TpL2/Cot is a serine kinase with the ability to phosphorylate MEK1 and activate ERK MAP kinase (Hagemann et al., 1999; Patriotis et al., 1994; Salmeron, 1996) . This kinase was originally identi®ed as an oncogene associated with the development of Moloney murine leukemia virus-induced lymphomas Patriotis et al., 1993) . Thus, it is conceivable that TpL2/Cot constitutively activates Id gene expression in thymocytes, leading to the inappropriate inactivation of E2A and ultimately resulting in lymphomagenesis.
Regulation of Id3 by TGF-b
In addition to regulation by the Ras/ERK MAP kinase pathway Id gene expression has recently been shown to be regulated by other signaling pathways, including BMP and TGF-b (Hollnagel et al., 1999; Kee et al., 2001) . TGF-b is a pleiotropic cytokine produced by all cells in the bone marrow. TGF-b initiates signaling by binding a heterodimeric receptor complex with serine and threonine kinase activity (Baker and Harland, 1997; Massague, 1998) . Once activated, this receptor phosphorylates Smad2 and Smad3, which then associate with Smad4. This trimeric complex translocates to the nucleus and activates downstream gene expression (Massague, 1998) . This signaling pathway can also lead to the upregulation of Smad7, an inhibitory molecule that binds to the receptor and inhibits further TGF-b mediated signaling (Hayashi et al., 1997; Nakao et al., 1997) . TGF-b has been reported to be a strong inhibitor of lymphocyte growth and survival (Chantry et al., 1989; Lee et al., 1989) . In vivo, transgenic mice expressing a dominant negative TGFb receptor and mice de®cient for TGF-b1 exhibit self-reactive lymphocytes (Gorelik and Flavell, 2000; Kulkarni et al., 1993; Shull et al., 1992; Yaswen et al., 1996) . Expression of bone morphogenic protein 4 (BMP-4), a TGF-b related protein, in ES cells leads to an induction of Id2 and Id3 expression (Hollnagel et al., 1999) . Similarly, treatment of neuroepithelial cells with BMP-2 induced expression of Id1 and Id3 (Nakashima et al., 2001) . Additionally, Id1 expression is induced in hepatocyte cultures treated with TGF-b (Lilja et al., 1999) . When B-lymphocyte progenitors (BLPs) in culture were treated with TGF-b, Id3 transcription was rapidly induced (Kee et al., 2001) . Interestingly, although inhibition of cell growth was still observed in BLPs from Id3 null mutant mice treated with TGF-b1, it was signi®cantly delayed compared to BLPs from wild-type mice (Kee et al., 2001) . These data suggest that TGF-b signaling has the ability to regulate cell cycle progression in developing B lineage cells in part through regulation of E-proteins ( Figure 4B ). It has recently been reported that Id2 is required to promote cell growth in mouse embryonic ®broblasts (Lasorella et al., 2000) . Furthermore, Id2 is downregulated by TGF-b in mouse embryonic ®broblasts and other cell types (Lasorella et al., 2000) . Although these results seem contrary to those discussed above, it is possible that the induction of Id proteins in response to TGF-b signaling is cell type speci®c.
Conclusions and future directions
Given the wide tissue distribution of both E2A and Id gene expression, it is conceivable that both of these proteins contribute to the malignant transformation of other cell types that harbor activated Ras. Most E2A de®cient mice succumb to malignant thymomas that arise within a three month period (Bain et al., 1997a; Yan et al., 1997) . To date, no other neoplasias have been observed. However, other tumors could ultimately develop if the mice did not succumb to rapidly developing thymomas. Additionally, since E2A is coexpressed with other E-proteins in many tissue types, it is possible that a functional redundancy exists, preventing the progression of non-T cell tumors in E47 de®cient mice. We note that Id2 expression is also regulated by the Ras Erk MAP kinase pathway (G Bain and C Murre, unpublished results). In addition, elevated Id2 transcript levels are present in a wide variety of human pancreatic cancers (Klee et al., 1998) . Thus, it is conceivable that activation of the Ras pathway may lead to the inappropriate expression of members of the Id gene family. Since mutations in Ras are among the most frequent in human cancers it will be important to determine whether E2A activity is modulated in such neoplasias.
Interestingly, recent data have also shown that the Id2 gene is directly regulated by the proto-oncogene cmyc (Lasorella et al., 2000) . It is intriguing that this particular class of proteins is regulated by the Ras and BMP/TGF-b signaling pathways as well as by the myc proteins. How the convergence of these key regulatory molecules modulate the expression of the Id genes is an intriguing issue. It will be particularly important to analyse precisely how myc, TGF-b and Ras modulate the activity of this particular class of inhibitory HLH proteins.
